Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 392, Issue 2, pp 159–164 | Cite as

All-trans retinoic acid prevents cisplatin-induced nephrotoxicity in rats

  • Cem YucelEmail author
  • Elcin Erdogan Yucel
  • Fatma Demet Arslan
  • Sumeyye Ekmekci
  • Erdem Kisa
  • Volkan Ulker
  • Murat Ucar
  • Yusuf Ozlem Ilbey
  • Orcun Celik
  • Banu Isbilen Basok
  • Zafer Kozacioglu
Original Article

Abstract

The aim of this study is to investigate the effects of all-trans retinoic acid (ATRA) use on cisplatin (CP)-induced nephrotoxicty. Twenty-eight rats were randomly divided into four groups. The rats in the control group were injected a single dose of 1 ml/kg saline intra-peritoneally (IP) during 10 days. The rats in the ATRA group were injected a single dose of ATRA during 10 days. The rats in the ATRA+CP group were injected a single dose of CP on the fourth day of the 10 days of ATRA treatment. The rats in the CP group were injected a single dose of CP on the fourth day of 10 days without administering a treatment. After treatment, the groups were compared with regard to total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) levels in renal tissue and renal histopathology. The serum creatinine and urea values were statistically significantly higher in the CP group compared to the other groups. The serum creatinine and urea values were statistically significantly lower in the ATRA+CP group when compared to the CP group. Although the TOS and OSI levels were found to be lower in the ATRA+CP group compared to the CP group, the difference was not statistically significant. Administration of ATRA together with CP was observed to reduce the histopathologic destruction in the kidney and lead to mild tubular degeneration, vacuolization, and necrosis (57.1% grade 1; 28.6% grade2, and 14.3% grade 3 necrosis). The results of the present study have revealed that ATRA administration ameliorates CP-induced nephrotoxicity; however, further studies are required to identify this issue before clinical application.

Keywords

Nephrotoxicity All-trans retinoic acid Cisplatin 

Notes

Acknowledgements

We would like to thank to Pelin Teke Kisa, Serdar Bayrak, and Ozgur Cakmak for their contribution to the statistical analysis.

Author contributions

CY and EEY conceived and designed research. CY, FDA, and SE conducted experiments. EK, VU, and MU contributed new reagents or analytical tools. CY and OC analyzed data. YOI, BB, and ZK made supervision. CY wrote the manuscript. All authors read and approved the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

All procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the Research Council after approval had been obtained from the Dokuz Eylül University local ethical committee of animal experiments.

References

  1. Aburto A, Barria A, Cardenas A, Carpio D, Figueroa CD, Burgos ME, Ardiles L (2014) Pre-stimulation of the kallikrein system in cisplatin-induced acute renal injury: an approach to renoprotection. Toxicol Appl Pharmacol 280(2):216–223.  https://doi.org/10.1016/j.taap.2014.07.023 CrossRefGoogle Scholar
  2. Alibakhshi T, Khodayar MJ, Khorsandi L, Rashno M, Zeidooni L (2018) Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomed Pharmacother 105:225–232.  https://doi.org/10.1016/j.biopha.2018.05.085 CrossRefGoogle Scholar
  3. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460–464CrossRefGoogle Scholar
  4. Bouhadjari N, Gabato W, Calabrese D, Msika S, Keita H (2016) Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol 42(2):219–223.  https://doi.org/10.1016/j.ejso.2015.07.016 CrossRefGoogle Scholar
  5. Cekmen M, Ilbey YO, Ozbek E, Simsek A, Somay A, Ersoz C (2009) Curcumin prevents oxidative renal damage induced by acetaminophen in rats. Food Chem Toxicol 47(7):1480–1484.  https://doi.org/10.1016/j.fct.2009.03.034 CrossRefGoogle Scholar
  6. Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI (2017) A systematic review of strategies to prevent cisplatin-induced nephrotoxicity. Oncologist 22(5):609–619.  https://doi.org/10.1634/theoncologist.2016-0319 CrossRefGoogle Scholar
  7. Elsayed AM, Abdelghany TM, Akool el S, Abdel-Aziz AA, Abdel-Bakky MS (2016) All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway. Naunyn Schmiedeberg’s Arch Pharmacol 389(3):327–337.  https://doi.org/10.1007/s00210-015-1193-3 CrossRefGoogle Scholar
  8. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37(2):112–119CrossRefGoogle Scholar
  9. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12):1103–1111.  https://doi.org/10.1016/j.clinbiochem.2005.08.008 CrossRefGoogle Scholar
  10. Ewees MG, Abdelghany TM, Abdel-Aziz AA, Abdel-Bakky MS (2015) All-trans retinoic acid mitigates methotrexate-induced liver injury in rats; relevance of retinoic acid signaling pathway. Naunyn Schmiedeberg's Arch Pharmacol 388(9):931–938.  https://doi.org/10.1007/s00210-015-1130-5 CrossRefGoogle Scholar
  11. Ezaki T, Nishiumi S, Azuma T, Yoshida M (2017) Metabolomics for the early detection of cisplatin-induced nephrotoxicity. Toxicol Res (Camb) 6(6):843–853.  https://doi.org/10.1039/c7tx00171a CrossRefGoogle Scholar
  12. Gomez-Sierra T, Eugenio-Perez D, Sanchez-Chinchillas A, Pedraza-Chaverri J (2018) Role of food-derived antioxidants against cisplatin induced-nephrotoxicity. Food Chem Toxicol 120:230–242.  https://doi.org/10.1016/j.fct.2018.07.018 CrossRefGoogle Scholar
  13. Gudas LJ (2012) Emerging roles for retinoids in regeneration and differentiation in normal and disease states. Biochim Biophys Acta 1821(1):213–221.  https://doi.org/10.1016/j.bbalip.2011.08.002 CrossRefGoogle Scholar
  14. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR (2004) Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 82(6):568–576.  https://doi.org/10.1111/j.1440-1711.2004.01287.x CrossRefGoogle Scholar
  15. Ilbey YO, Ozbek E, Cekmen M, Somay A, Ozcan L, Otunctemur A, Simsek A, Mete F (2009) Melatonin prevents acetaminophen-induced nephrotoxicity in rats. Int Urol Nephrol 41(3):695–702.  https://doi.org/10.1007/s11255-008-9503-z CrossRefGoogle Scholar
  16. Jung K, An JM, Eom DW, Kang KS, Kim SN (2017) Preventive effect of fermented black ginseng against cisplatin-induced nephrotoxicity in rats. J Ginseng Res 41(2):188–194.  https://doi.org/10.1016/j.jgr.2016.03.001 CrossRefGoogle Scholar
  17. Kavukcu S, Turkmen MA, Soylu A (2001) Could the effective mechanisms of retinoids on nephrogenesis be also operative on the amelioration of injury in acquired renal lesions? Pediatr Nephrol 16(8):689–690CrossRefGoogle Scholar
  18. Kim CS, Park JS, Ahn CW, Kim KR (2015) All-trans retinoic acid has a potential therapeutic role for diabetic nephropathy. Yonsei Med J 56(6):1597–1603.  https://doi.org/10.3349/ymj.2015.56.6.1597 CrossRefGoogle Scholar
  19. Lelievre-Pegorier M, Vilar J, Ferrier ML, Moreau E, Freund N, Gilbert T, Merlet-Benichou C (1998) Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 54(5):1455–1462.  https://doi.org/10.1046/j.1523-1755.1998.00151.x CrossRefGoogle Scholar
  20. Moreb JS, Ucar-Bilyeu DA, Khan A (2017) Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells. Cancer Chemother Pharmacol 79(2):295–301.  https://doi.org/10.1007/s00280-016-3213-5 CrossRefGoogle Scholar
  21. Moulder JE, Fish BL, Regner KR, Cohen EP, Raife TJ (2002) Retinoic acid exacerbates experimental radiation nephropathy. Radiat Res 157(2):199–203CrossRefGoogle Scholar
  22. Nematbakhsh M, Ashrafi F, Pezeshki Z, Fatahi Z, Kianpoor F, Sanei MH, Talebi A (2012) A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: which one is the first observation as side effect of Cisplatin-induced toxicity in animal model? J Nephropathol 1(3):190–193.  https://doi.org/10.5812/nephropathol.8122 CrossRefGoogle Scholar
  23. Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, Yamamoto T, Imai E, Hori M (2003) Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 64(4):1241–1252.  https://doi.org/10.1046/j.1523-1755.2003.00219.x CrossRefGoogle Scholar
  24. Ozbek E, Ilbey YO, Simsek A, Cekmen M, Mete F, Somay A (2010) Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats. Int Urol Nephrol 42(3):579–587.  https://doi.org/10.1007/s11255-009-9645-7 CrossRefGoogle Scholar
  25. Penniston KL, Tanumihardjo SA (2006) The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 83(2):191–201.  https://doi.org/10.1093/ajcn/83.2.191 CrossRefGoogle Scholar
  26. Saifi MA, Sangomla S, Khurana A, Godugu C (2018) Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms. Biol Trace Elem Res 1:1–12Google Scholar
  27. Tang XH, Gudas LJ (2011) Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol 6:345–364.  https://doi.org/10.1146/annurev-pathol-011110-130303 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Cem Yucel
    • 1
    Email author
  • Elcin Erdogan Yucel
    • 2
  • Fatma Demet Arslan
    • 3
  • Sumeyye Ekmekci
    • 4
  • Erdem Kisa
    • 1
  • Volkan Ulker
    • 1
  • Murat Ucar
    • 1
  • Yusuf Ozlem Ilbey
    • 1
  • Orcun Celik
    • 1
  • Banu Isbilen Basok
    • 3
  • Zafer Kozacioglu
    • 1
  1. 1.Department of UrologyTepecik Training and Research HospitalİzmirTurkey
  2. 2.Department of Internal MedicineTepecik Training and Research HospitalİzmirTurkey
  3. 3.Department of Medical BiochemistryTepecik Training and Research HospitalİzmirTurkey
  4. 4.Department of PathologyTepecik Training and Research HospitalİzmirTurkey

Personalised recommendations